Cargando…
Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway
In the present study, SGC-7901/DDP cells were treated with different concentrations of parthenolide (PN) (2.5–15 µmol/l), cisplatin (DDP) (1.25–15 µg/ml) and PN+DDP. The proliferation inhibition rates were measured using an MTT assay, and the synergies of PN and DDP were analyzed. The effect of PN a...
Autores principales: | Li, Hua, Lu, Hang, Lv, Meng, Wang, Qingsheng, Sun, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796286/ https://www.ncbi.nlm.nih.gov/pubmed/29467878 http://dx.doi.org/10.3892/ol.2018.7739 |
Ejemplares similares
-
Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases
por: Liu, Man, et al.
Publicado: (2018) -
Inhibition of microtubule detyrosination by parthenolide facilitates functional CNS axon regeneration
por: Leibinger, Marco, et al.
Publicado: (2023) -
Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro
por: Liu, Jun-Wei, et al.
Publicado: (2010) -
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
por: Jorge, Joana, et al.
Publicado: (2023) -
Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis
por: Cui, Meng, et al.
Publicado: (2022)